Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 13, 2022

SELL
$255.51 - $362.11 $18,396 - $26,071
-72 Closed
0 $0
Q2 2021

Aug 13, 2021

SELL
$294.17 - $371.65 $23,533 - $29,732
-80 Reduced 52.63%
72 $27,000
Q1 2020

May 06, 2020

SELL
$98.9 - $178.34 $296 - $535
-3 Reduced 1.94%
152 $19,000
Q1 2018

May 14, 2018

BUY
$98.19 - $115.2 $15,219 - $17,856
155 New
155 $17,000

Others Institutions Holding CRL

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.


  • Ticker CRL
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 50,863,300
  • Market Cap $10.1B
  • Description
  • Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...
More about CRL
Track This Portfolio

Track Fuller & Thaler Asset Management, Inc. Portfolio

Follow Fuller & Thaler Asset Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fuller & Thaler Asset Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Fuller & Thaler Asset Management, Inc. with notifications on news.